Summary
Pharmaceuticals in the United States industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The US pharmaceuticals market had total revenues of $387.0bn in 2020, representing a compound annual growth rate (CAGR) of 4.7% between 2016 and 2020.
- The US government has invested heavily in pharmaceutical companies in 2020 to accelerate the development of vaccines to safeguard its citizens from the coronavirus outbreak. This has aided a return to positive market growth.
- Plans to build on the Affordable Care Act under Joe Biden’s upcoming administration in 2021 could contribute to a slowdown in market growth as healthcare becomes more affordable and accessible, and the ability of pharmaceutical companies to freely set prices is limited.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in the United States
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in the United States
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the United States pharmaceuticals market with five year forecasts
Reasons to Buy
- What was the size of the United States pharmaceuticals market by value in 2020?
- What will be the size of the United States pharmaceuticals market in 2025?
- What factors are affecting the strength of competition in the United States pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in the United State's pharmaceuticals market?
'
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Market share
7.2. Who are the leading players?
7.3. What strategies do leading players follow?
7.4. What has been the rationale behind recent M&A activity?
7.5. How does government regulation impact leading players?
7.6. What impact is the COVID-19 pandemic having on the market?
8 Company Profiles
8.1. Johnson & Johnson
8.2. Pfizer Inc.
8.3. AstraZeneca PLC
8.4. Merck & Co., Inc.
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: United States pharmaceuticals market value: $ billion, 2016-20
Table 2: United States pharmaceuticals market geography segmentation: $ billion, 2020
Table 3: United States pharmaceuticals market value forecast: $ billion, 2020-25
Table 4: United States pharmaceuticals market share: % share, by value, 2020
Table 5: Johnson & Johnson: key facts
Table 6: Johnson & Johnson: Annual Financial Ratios
Table 7: Johnson & Johnson: Key Employees
Table 8: Johnson & Johnson: Key Employees Continued
Table 9: Pfizer Inc.: key facts
Table 10: Pfizer Inc.: Annual Financial Ratios
Table 11: Pfizer Inc.: Key Employees
Table 12: Pfizer Inc.: Key Employees Continued
Table 13: AstraZeneca PLC: key facts
Table 14: AstraZeneca PLC: Annual Financial Ratios
Table 15: AstraZeneca PLC: Key Employees
Table 16: Merck & Co., Inc.: key facts
Table 17: Merck & Co., Inc.: Annual Financial Ratios
Table 18: Merck & Co., Inc.: Key Employees
Table 19: Merck & Co., Inc.: Key Employees Continued
Table 20: United States size of population (million), 2016-20
Table 21: United States gdp (constant 2005 prices, $ billion), 2016-20
Table 22: United States gdp (current prices, $ billion), 2016-20
Table 23: United States inflation, 2016-20
Table 24: United States consumer price index (absolute), 2016-20
Table 25: United States exchange rate, 2016-20
List of Figures
Figure 1: United States pharmaceuticals market value: $ billion, 2016-20
Figure 2: United States pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 3: United States pharmaceuticals market value forecast: $ billion, 2020-25
Figure 4: Forces driving competition in the pharmaceuticals market in the United States, 2020
Figure 5: Drivers of buyer power in the pharmaceuticals market in the United States, 2020
Figure 6: Drivers of supplier power in the pharmaceuticals market in the United States, 2020
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United States, 2020
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in the United States, 2020
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in the United States, 2020
Figure 10: United States pharmaceuticals market share: % share, by value, 2020
